Article info

Original research
Selective androgen receptor modulation for muscle weakness in chronic obstructive pulmonary disease: a randomised control trial

Authors

  1. Correspondence to Professor Michael I Polkey, Imperial College London, London, London, UK; m.polkey{at}rbht.nhs.uk
View Full Text

Citation

Mohan D, Rossiter H, Watz H, et al
Selective androgen receptor modulation for muscle weakness in chronic obstructive pulmonary disease: a randomised control trial

Publication history

  • Received October 14, 2021
  • Accepted August 26, 2022
  • First published October 25, 2022.
Online issue publication 
May 11, 2023

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.